Back to Journals » OncoTargets and Therapy » Volume 13

RETRACTED ARTICLE: UPF1 Participates in the Progression of Endometrial Cancer by Inhibiting the Expression of lncRNA PVT1

Authors Xing T, Chen P, Wu J, Gao L, Yang W, Cheng Y, Tong L

Received 1 October 2019

Accepted for publication 18 December 2019

Published 9 March 2020 Volume 2020:13 Pages 2103—2114

DOI https://doi.org/10.2147/OTT.S233149

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Leo Jen-Liang Su



This paper has been retracted.

Xing T, Chen P, Wu J, et al. Onco Targets Ther. 2020;13:2103-2114.

We, the Editors and Publisher of OncoTargets and Therapy, have retracted the following article.

Following publication of the article, concerns were raised about the duplication of images from Figures 2 and 3 with images from other unrelated articles. Specifically,

  • Images for Figure 2D and 2H have been duplicated with images for Figure 1e from Liu S, Liu LH, Hu WW, Wang M. Long noncoding RNA TUG1 regulates the development of oral squamous cell carcinoma through sponging miR-524-5p to mediate DLX1 expression as a competitive endogenous RNA. J Cell Physiol. 2019;234:20206–20216. https://doi.org/10.1002/jcp.28620 and Figure 2E and 7F from Chen Y, Lei Y, Lin J, et al. The LINC01260 Functions as a Tumor Suppressor via the miR-562/CYLD/NF-κB Pathway in Non-Small Cell Lung Cancer. Onco Targets Ther. 2020;13:10707-10719. https://doi.org/10.2147/OTT.S253730 (RETRACTED).
  • Images for Figure 3D and 3H have been duplicated with images for Figure 1f from Liu et al, 2019 and Figures 3b and 5g from Xiong Y, Zhang J, Song C. CircRNA ZNF609 functions as a competitive endogenous RNA to regulate FOXP4 expression by sponging miR-138-5p in renal carcinoma. J Cell Physiol. 2019;234:10646–10654. https://doi.org/10.1002/jcp.27744.
  • In addition, images for Figure 6D, si NC and 6H, NC have been duplicated with images for Figure 7D, siUPF1 and siUPF1+siPVT1, respectively.

The authors did not respond to our queries and were unable to provide an explanation for the duplicated images or provide data for the study. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors were notified of this.

We have been informed in our decision-making by our editorial policies and COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

Creative Commons License © 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.